Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PRALATREXATE Cause C-reactive protein increased? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of C-reactive protein increased have been filed in association with PRALATREXATE (Pralatrexate). This represents 1.7% of all adverse event reports for PRALATREXATE.

8
Reports of C-reactive protein increased with PRALATREXATE
1.7%
of all PRALATREXATE reports
3
Deaths
4
Hospitalizations

How Dangerous Is C-reactive protein increased From PRALATREXATE?

Of the 8 reports, 3 (37.5%) resulted in death, 4 (50.0%) required hospitalization, and 5 (62.5%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PRALATREXATE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does PRALATREXATE Cause?

Malignant neoplasm progression (107) Stomatitis (93) Platelet count decreased (56) Disease progression (46) Neutrophil count decreased (40) Anaemia (39) Pyrexia (38) Mucosal inflammation (37) Drug ineffective (32) Off label use (30)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which PRALATREXATE Alternatives Have Lower C-reactive protein increased Risk?

PRALATREXATE vs PRALSETINIB PRALATREXATE vs PRAMIPEXOLE PRALATREXATE vs PRAMIPEXOLE\PRAMIPEXOLE PRALATREXATE vs PRAMLINTIDE PRALATREXATE vs PRASTERONE

Related Pages

PRALATREXATE Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased PRALATREXATE Demographics